• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实验室检测结果与综合多因素方法预测 COVID-19 危重症患者死亡:一项回顾性研究。

Laboratory findings and a combined multifactorial approach to predict death in critically ill patients with COVID-19: a retrospective study.

机构信息

Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.

出版信息

Epidemiol Infect. 2020 Jun 30;148:e129. doi: 10.1017/S0950268820001442.

DOI:10.1017/S0950268820001442
PMID:32600484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7343973/
Abstract

To describe the laboratory findings of cases of death with coronavirus disease 2019 (COVID-19) and to establish a scoring system for predicting death, we conducted this single-centre, retrospective, observational study including 336 adult patients (≥18 years old) with severe or critically ill COVID-19 admitted in two wards of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology in Wuhan, who had definite outcomes (death or discharge) between 1 February 2020 and 13 March 2020. Single variable and multivariable logistic regression analyses were performed to identify mortality-related factors. We combined multiple factors to predict mortality, which was validated by receiver operating characteristic curves. As a result, in a total of 336 patients, 34 (10.1%) patients died during hospitalisation. Through multivariable logistic regression, we found that decreased lymphocyte ratio (Lymr, %) (odds ratio, OR 0.574, P < 0.001), elevated blood urea nitrogen (BUN) (OR 1.513, P = 0.009), and raised D-dimer (DD) (OR 1.334, P = 0.002) at admission were closely related to death. The combined prediction model was developed by these factors with a sensitivity of 100.0% and specificity of 97.2%. In conclusion, decreased Lymr, elevated BUN, and raised DD were found to be in association with death outcomes in critically ill patients with COVID-19. A scoring system was developed to predict the clinical outcome of these patients.

摘要

为了描述 2019 年冠状病毒病(COVID-19)死亡病例的实验室检查结果,并建立预测死亡的评分系统,我们进行了这项单中心、回顾性、观察性研究,纳入了华中科技大学同济医学院附属协和医院两个病房的 336 例成人重症或危重症 COVID-19 患者(年龄≥18 岁),这些患者在 2020 年 2 月 1 日至 2020 年 3 月 13 日之间有明确的结局(死亡或出院)。我们采用单变量和多变量逻辑回归分析来确定与死亡率相关的因素。我们将多个因素结合起来预测死亡率,并通过接受者操作特征曲线进行验证。结果,在总共 336 例患者中,有 34 例(10.1%)患者在住院期间死亡。通过多变量逻辑回归,我们发现入院时淋巴细胞比值(Lymr,%)降低(优势比,OR 0.574,P<0.001)、血尿素氮(BUN)升高(OR 1.513,P=0.009)和 D-二聚体(DD)升高(OR 1.334,P=0.002)与死亡密切相关。该联合预测模型由这些因素构建,具有 100.0%的敏感性和 97.2%的特异性。总之,在 COVID-19 重症患者中,Lymr 降低、BUN 升高和 DD 升高与死亡结局相关。我们建立了一个评分系统来预测这些患者的临床结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef78/7343973/92c3b7968efd/S0950268820001442_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef78/7343973/d5981ca8e41c/S0950268820001442_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef78/7343973/b53a88ca0cf9/S0950268820001442_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef78/7343973/92c3b7968efd/S0950268820001442_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef78/7343973/d5981ca8e41c/S0950268820001442_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef78/7343973/b53a88ca0cf9/S0950268820001442_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef78/7343973/92c3b7968efd/S0950268820001442_fig3.jpg

相似文献

1
Laboratory findings and a combined multifactorial approach to predict death in critically ill patients with COVID-19: a retrospective study.实验室检测结果与综合多因素方法预测 COVID-19 危重症患者死亡:一项回顾性研究。
Epidemiol Infect. 2020 Jun 30;148:e129. doi: 10.1017/S0950268820001442.
2
Diagnostic performance of initial blood urea nitrogen combined with D-dimer levels for predicting in-hospital mortality in COVID-19 patients.初始血尿素氮联合 D-二聚体水平对预测 COVID-19 患者住院死亡率的诊断性能。
Int J Antimicrob Agents. 2020 Sep;56(3):106110. doi: 10.1016/j.ijantimicag.2020.106110. Epub 2020 Jul 23.
3
Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study.与严重新型冠状病毒病(COVID-19)患者死亡结局相关的因素:病例对照研究。
Int J Med Sci. 2020 May 18;17(9):1281-1292. doi: 10.7150/ijms.46614. eCollection 2020.
4
Impaired immune and coagulation systems may be early risk factors for COVID-19 patients: A retrospective study of 118 inpatients from Wuhan, China.免疫和凝血系统受损可能是新冠病毒肺炎患者的早期危险因素:一项对118例来自中国武汉住院患者的回顾性研究。
Medicine (Baltimore). 2020 Aug 28;99(35):e21700. doi: 10.1097/MD.0000000000021700.
5
Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.新冠肺炎患者 D-二聚体和中性粒细胞-淋巴细胞比值的动态变化作为预后生物标志物。
Respir Res. 2020 Jul 3;21(1):169. doi: 10.1186/s12931-020-01428-7.
6
Laboratory Findings Associated With Severe Illness and Mortality Among Hospitalized Individuals With Coronavirus Disease 2019 in Eastern Massachusetts.马萨诸塞州东部住院的 2019 年冠状病毒病患者中严重疾病和死亡相关的实验室检查结果。
JAMA Netw Open. 2020 Oct 1;3(10):e2023934. doi: 10.1001/jamanetworkopen.2020.23934.
7
A nomogram for predicting mortality in patients with COVID-19 and solid tumors: a multicenter retrospective cohort study.用于预测 COVID-19 合并实体瘤患者死亡率的列线图:一项多中心回顾性队列研究。
J Immunother Cancer. 2020 Sep;8(2). doi: 10.1136/jitc-2020-001314.
8
D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19.入院时 D-二聚体水平预测 COVID-19 患者住院死亡率。
J Thromb Haemost. 2020 Jun;18(6):1324-1329. doi: 10.1111/jth.14859.
9
[Relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019].2019冠状病毒病患者D-二聚体浓度与炎症因子或器官功能的关系
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 May;32(5):559-563. doi: 10.3760/cma.j.cn121430-20200414-00518.
10
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.

引用本文的文献

1
Machine Learning-Based Identification of Risk Factors for ICU Mortality in 8902 Critically Ill Patients with Pandemic Viral Infection.基于机器学习对8902例大流行性病毒感染重症患者ICU死亡风险因素的识别
J Clin Med. 2025 Jul 30;14(15):5383. doi: 10.3390/jcm14155383.
2
Inflammatory biomarkers and adverse outcome in COVID-19: Prelude for future viral pandemics.新冠病毒肺炎中的炎症生物标志物与不良结局:未来病毒性大流行的前奏
J Family Med Prim Care. 2025 Feb;14(2):720-728. doi: 10.4103/jfmpc.jfmpc_1326_24. Epub 2025 Feb 21.
3
Prognostic models in COVID-19 infection that predict severity: a systematic review.

本文引用的文献

1
Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉 2019 年新型冠状病毒感染患者的放射学表现与死亡率的相关性研究。
PLoS One. 2020 Mar 19;15(3):e0230548. doi: 10.1371/journal.pone.0230548. eCollection 2020.
2
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.洛匹那韦-利托那韦治疗成人重症 COVID-19 患者的临床试验。
N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.
3
Early estimation of the case fatality rate of COVID-19 in mainland China: a data-driven analysis.
COVID-19 感染中预测严重程度的预后模型:系统评价。
Eur J Epidemiol. 2023 Apr;38(4):355-372. doi: 10.1007/s10654-023-00973-x. Epub 2023 Feb 25.
4
Deep-Risk: Deep Learning-Based Mortality Risk Predictive Models for COVID-19.深度风险:基于深度学习的新冠病毒疾病死亡风险预测模型
Diagnostics (Basel). 2022 Jul 30;12(8):1847. doi: 10.3390/diagnostics12081847.
5
Coagulation parameters abnormalities and their relation to clinical outcomes in hospitalized and severe COVID-19 patients: prospective study.住院和重症 COVID-19 患者的凝血参数异常及其与临床结局的关系:前瞻性研究。
Sci Rep. 2022 Aug 1;12(1):13155. doi: 10.1038/s41598-022-16915-8.
6
An Imaging Overview of COVID-19 ARDS in ICU Patients and Its Complications: A Pictorial Review.ICU 患者中 COVID-19 急性呼吸窘迫综合征及其并发症的影像学概述:图文综述
Diagnostics (Basel). 2022 Mar 29;12(4):846. doi: 10.3390/diagnostics12040846.
7
Diagnostic Approaches for COVID-19 and Its Associated Complications.新型冠状病毒肺炎及其相关并发症的诊断方法
Diagnostics (Basel). 2021 Nov 9;11(11):2071. doi: 10.3390/diagnostics11112071.
8
D-dimer, disease severity, and deaths (3D-study) in patients with COVID-19: a systematic review and meta-analysis of 100 studies.COVID-19 患者的 D-二聚体、疾病严重程度和死亡(3D 研究):100 项研究的系统评价和荟萃分析。
Sci Rep. 2021 Nov 8;11(1):21888. doi: 10.1038/s41598-021-01462-5.
9
Evaluating risk stratification scoring systems to predict mortality in patients with COVID-19.评估风险分层评分系统以预测 COVID-19 患者的死亡率。
BMJ Health Care Inform. 2021 Sep;28(1). doi: 10.1136/bmjhci-2021-100389.
10
Machine Learning Algorithms are Superior to Conventional Regression Models in Predicting Risk Stratification of COVID-19 Patients.机器学习算法在预测COVID-19患者的风险分层方面优于传统回归模型。
Risk Manag Healthc Policy. 2021 Jul 29;14:3159-3166. doi: 10.2147/RMHP.S318265. eCollection 2021.
中国大陆地区新型冠状病毒肺炎病死率的早期估计:一项基于数据的分析
Ann Transl Med. 2020 Feb;8(4):128. doi: 10.21037/atm.2020.02.66.
4
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
5
SARS-CoV-2 is an appropriate name for the new coronavirus.严重急性呼吸综合征冠状病毒2型是这种新型冠状病毒的恰当名称。
Lancet. 2020 Mar 21;395(10228):949-950. doi: 10.1016/S0140-6736(20)30557-2. Epub 2020 Mar 6.
6
Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease.分析与 2019 年新型冠状病毒病住院患者疾病结局相关的因素。
Chin Med J (Engl). 2020 May 5;133(9):1032-1038. doi: 10.1097/CM9.0000000000000775.
7
World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19).世界卫生组织宣布全球紧急状态:对 2019 年新型冠状病毒(COVID-19)的回顾。
Int J Surg. 2020 Apr;76:71-76. doi: 10.1016/j.ijsu.2020.02.034. Epub 2020 Feb 26.
8
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
9
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.中国武汉严重 COVID-19 患者的临床病程和结局:一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.
10
Understanding of COVID-19 based on current evidence.基于现有证据对 COVID-19 的理解。
J Med Virol. 2020 Jun;92(6):548-551. doi: 10.1002/jmv.25722. Epub 2020 Mar 5.